Anne M. Nunes

Anne M. Nunes

Former SVP, Chief Operations OfficeratAnika Therapeutics· In proxies 2023–2025

Pay in FY2024+12% from the year before · Anika Therapeutics stock -27.4% the same year

Anne M. Nunes was paid $1.1M in FY2024 (Dec), up 12%. Anika Therapeutics stock fell 27.4% that year.

Pay$100 in the stock at the end of FY22 → $56
Pay is from the Summary Compensation Table of each Anika Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Anika TherapeuticsPublic company · 3 yr
    • Former SVP, Chief Operations Officer2023 – Present · 3 yrStock in role -24%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?